Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma.

Front Immunol · 2023 · PMC10611477 · PMID 37901237

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The results showed a remarkable and highly significant increase of cleaved caspase-3 as the main apoptotic marker in the combination group [ADU-S100 (20 μg) + CpG ODN (20 μg)].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.